Dr. John Albracht - retroperitoneal lymphoma

 

 

 
Audio When available


 
 
Video When available


 
 

Archived from Charlotte Gerson's booklet

Story

   This 59 year old doctor of chiropractic medicine was first treated
for mixed cell lymphoma in 1963. Surgery was performed by
Charles Y. Mayo, Jr. On laparotomy, Dr. Mayo discovered a large,
inoperable, irregular retroperitoneal tumor pushing up through
the mesentery of the small bowel. Dr. Albracht subsequently
submitted to 20 fractions of cobalt radiotherapy. Exposure was
3,900 roentgens each to the front and the back of the abdomen, a
total of 7,800 roentgens. The mass shrank rapidly, and Dr.
Albracht remained in remission for 24 years. On December 1,
1986 he presented to High Plains Baptist Hospital with severe
gastrointestinal bleeding, profuse sweating, weakness, gas, belching,
indigestion, epigastric fullness, diarrhea, abnormally rapid
heartbeat, hemoglobin of 8, and hematocrit of 26.

   On December 5,1986, a small bowel resection with end-to-end
anastomosis was performed by Dr. Gregorio Matos. An extensive
lymphoma involved one third of the small bowel and extended to
the mesothelium, involving the second portion of the small
intestine, down to the proximal ileum. A tumor the size of a
cantaloupe was removed with seven feet of small bowel. The
laboratory finding was malignant lymphoma, diffuse, mixed small
and large cell type, sclerosing (mesentery). Dr. Albracht was
evaluated for chemotherapy by Dr. Karim Nawaz, and plans were
made for systemic treatment with Cytoxan, Adriamycin, Vincristine,
Bleomycin and Prednisone. He tolerated two treatments, on
January 11 and February 3, 1987, and voluntarily discontinued
after his weight dropped from 185 to 130 pounds.

   He was admitted with residual abdominal disease to the Gerson
Therapy Center of Mexico on February 17, 1987. His treatment
was uneventful. He remained in follow-up with Dr. Matos and Dr.
Nawaz, and was seen for radiotherapy evaluation by Dr. Joseph
Arko on July 17,1987. He was found on examination to still have
some palpable residual disease, a 4 by 7 cm mass just to the right
of the umbilicus, although both Dr. Matos and Dr. Nawaz
reported that the mass was getting smaller. Dr. Arko felt that the
previous treatment (1963) was extensive enough to rule out
further radiotherapy, because all relevant tissues were near total
maximum radiotherapy tolerance. Dr. Arko noted that the patient
appeared younger than his stated age.

   By the close of 1987, with Dr. Albracht following the Gerson
diet therapy for cancer, the mass was no longer detectable.

   On his 70th birthday, in February 2002, Dr. Albracht reported
that he is very well, still active in his office two days a week.


 
 
Update When available